APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antibody Services

Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.

Selected research

Market Analysis & Forecast

Global Antibody Services Market Analysis and Forecast 2026-2032

26 December 2025192 pages

Choose your research edition.

Industry ResearchAntibody Services Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Antibody Services Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Antibody Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antibody Services Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Antibody Services Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.

Thermo Fisher ranks the first in terms of revenue share in global market of Antibody Services, occupies 18% of the global market share. While, Covance, with a market share of 14%, comes the second. All the other manufacturers which are not included in the report together consist of approximately 46% of the global market.

North America ranks the top in terms of market size of Antibody Services, which alone consists of 40% of the global market. Europe comes the second, with 31% of the global market. Asia Pacific ranks the third, consists of about 18% of the global antibody service market in the same year. All the other regions combined occupy only 8% of the global Antibody Service market.

Read the full market overview

Report Includes

This report presents an overview of global market for Antibody Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Antibody Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Antibody Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antibody Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antibody Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Antibody Services revenue, projected growth trends, production technology, application and end-user industry.

Antibody Services Segment by Company

ThermoFisher

GenScript

Abcam

MBS

ROCKLAND

ProSci

Anaspec

Bio-Rad

Covance

Capra Science

Innovagen

APS

Randox

GL Biochem

Abgent

Antibody Services Segment by Type

Monoclonal

Polyclonal

Others

Antibody Services Segment by Application

BioScience Companies

BioScience Research Institutions

Hospitals

Other

Antibody Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antibody Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Antibody Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Antibody Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibody Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antibody Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Monoclonal Major Player Table 3. Polyclonal Major Player Table 4. Others Major Player Table 5. Global Antibody Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. BioScience Companies Major Player Table 7. BioScience Research Institutions Major Player Table 8. Hospitals Major Player Table 9. Other Major Player Table 10. Antibody Services Industry Trends Table 11. Antibody Services Industry Drivers Table 12. Antibody Services Industry Opportunities and Challenges Table 13. Antibody Services Industry Restraints Table 14. Global Antibody Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Antibody Services Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Antibody Services Market Share by Region (2021-2026) Table 17. Global Antibody Services Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Antibody Services Market Share by Region (2027-2032) Table 19. Global Antibody Services Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Antibody Services Revenue Market Share by Players (2021-2026) Table 21. Global Antibody Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Antibody Services Key Players Headquarters & Area Served Table 23. Global Antibody Services Players, Product Type & Application Table 24. Global Antibody Services Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Antibody Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Antibody Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Antibody Services Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Antibody Services Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Antibody Services Revenue Market Share by Type (2021-2026) Table 31. Global Antibody Services Revenue Market Share by Type (2027-2032) Table 32. Global Antibody Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Antibody Services Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Antibody Services Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Antibody Services Revenue Market Share by Application (2021-2026) Table 36. Global Antibody Services Revenue Market Share by Application (2027-2032) Table 37. ThermoFisher Company Information Table 38. ThermoFisher Business Overview Table 39. ThermoFisher Antibody Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. ThermoFisher Antibody Services Product Portfolio Table 41. ThermoFisher Recent Development Table 42. GenScript Company Information Table 43. GenScript Business Overview Table 44. GenScript Antibody Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. GenScript Antibody Services Product Portfolio Table 46. GenScript Recent Development Table 47. Abcam Company Information Table 48. Abcam Business Overview Table 49. Abcam Antibody Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Abcam Antibody Services Product Portfolio Table 51. Abcam Recent Development Table 52. MBS Company Information Table 53. MBS Business Overview Table 54. MBS Antibody Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. MBS Antibody Services Product Portfolio Table 56. MBS Recent Development Table 57. ROCKLAND Company Information Table 58. ROCKLAND Business Overview Table 59. ROCKLAND Antibody Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. ROCKLAND Antibody Services Product Portfolio Table 61. ROCKLAND Recent Development Table 62. ProSci Company Information Table 63. ProSci Business Overview Table 64. ProSci Antibody Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. ProSci Antibody Services Product Portfolio Table 66. ProSci Recent Development Table 67. Anaspec Company Information Table 68. Anaspec Business Overview Table 69. Anaspec Antibody Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Anaspec Antibody Services Product Portfolio Table 71. Anaspec Recent Development Table 72. Bio-Rad Company Information Table 73. Bio-Rad Business Overview Table 74. Bio-Rad Antibody Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Bio-Rad Antibody Services Product Portfolio Table 76. Bio-Rad Recent Development Table 77. Covance Company Information Table 78. Covance Business Overview Table 79. Covance Antibody Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Covance Antibody Services Product Portfolio Table 81. Covance Recent Development Table 82. Capra Science Company Information Table 83. Capra Science Business Overview Table 84. Capra Science Antibody Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Capra Science Antibody Services Product Portfolio Table 86. Capra Science Recent Development Table 87. Innovagen Company Information Table 88. Innovagen Business Overview Table 89. Innovagen Antibody Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 90. Innovagen Antibody Services Product Portfolio Table 91. Innovagen Recent Development Table 92. APS Company Information Table 93. APS Business Overview Table 94. APS Antibody Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. APS Antibody Services Product Portfolio Table 96. APS Recent Development Table 97. Randox Company Information Table 98. Randox Business Overview Table 99. Randox Antibody Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 100. Randox Antibody Services Product Portfolio Table 101. Randox Recent Development Table 102. GL Biochem Company Information Table 103. GL Biochem Business Overview Table 104. GL Biochem Antibody Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 105. GL Biochem Antibody Services Product Portfolio Table 106. GL Biochem Recent Development Table 107. Abgent Company Information Table 108. Abgent Business Overview Table 109. Abgent Antibody Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 110. Abgent Antibody Services Product Portfolio Table 111. Abgent Recent Development Table 112. North America Antibody Services Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Antibody Services Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Antibody Services Revenue by Application (2021-2026) & (US$ Million) Table 115. North America Antibody Services Revenue by Application (2027-2032) & (US$ Million) Table 116. North America Antibody Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America Antibody Services Revenue by Country (2021-2026) & (US$ Million) Table 118. North America Antibody Services Revenue by Country (US$ Million) & (2027-2032) Table 119. Europe Antibody Services Revenue by Type (2021-2026) & (US$ Million) Table 120. Europe Antibody Services Revenue by Type (2027-2032) & (US$ Million) Table 121. Europe Antibody Services Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Antibody Services Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Antibody Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe Antibody Services Revenue by Country (2021-2026) & (US$ Million) Table 125. Europe Antibody Services Revenue by Country (US$ Million) & (2027-2032) Table 126. China Antibody Services Revenue by Type (2021-2026) & (US$ Million) Table 127. China Antibody Services Revenue by Type (2027-2032) & (US$ Million) Table 128. China Antibody Services Revenue by Application (2021-2026) & (US$ Million) Table 129. China Antibody Services Revenue by Application (2027-2032) & (US$ Million) Table 130. Asia Antibody Services Revenue by Type (2021-2026) & (US$ Million) Table 131. Asia Antibody Services Revenue by Type (2027-2032) & (US$ Million) Table 132. Asia Antibody Services Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia Antibody Services Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Antibody Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Asia Antibody Services Revenue by Region (US$ Million) & (2021-2026) Table 136. Asia Antibody Services Revenue by Region (US$ Million) & (2027-2032) Table 137. SAMEA Antibody Services Revenue by Type (2021-2026) & (US$ Million) Table 138. SAMEA Antibody Services Revenue by Type (2027-2032) & (US$ Million) Table 139. SAMEA Antibody Services Revenue by Application (2021-2026) & (US$ Million) Table 140. SAMEA Antibody Services Revenue by Application (2027-2032) & (US$ Million) Table 141. SAMEA Antibody Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. SAMEA Antibody Services Revenue by Country (2021-2026) & (US$ Million) Table 143. SAMEA Antibody Services Revenue by Country (US$ Million) & (2027-2032) Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Antibody Services Image Figure 2. Global Antibody Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antibody Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Monoclonal Image Figure 5. Polyclonal Image Figure 6. Others Image Figure 7. Global Antibody Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Antibody Services Market Size Share 2021 VS 2025 VS 2032 Figure 9. BioScience Companies Image Figure 10. BioScience Research Institutions Image Figure 11. Hospitals Image Figure 12. Other Image Figure 13. Global Antibody Services Market Size (US$ Million) & (2021-2032) Figure 14. Global Antibody Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Antibody Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Antibody Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Antibody Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Antibody Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Antibody Services Revenue Market Share by Type (2021-2032) Figure 21. Global Antibody Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Antibody Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Antibody Services Revenue Market Share by Application (2021-2032) Figure 24. North America Antibody Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Antibody Services Revenue Share by Type (2021-2032) Figure 26. North America Antibody Services Revenue Share by Application (2021-2032) Figure 27. North America Antibody Services Revenue Share by Country (2021-2032) Figure 28. United States Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Antibody Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Antibody Services Revenue Share by Type (2021-2032) Figure 33. Europe Antibody Services Revenue Share by Application (2021-2032) Figure 34. Europe Antibody Services Revenue Share by Country (2021-2032) Figure 35. Germany Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Antibody Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Antibody Services Revenue Share by Type (2021-2032) Figure 45. China Antibody Services Revenue Share by Application (2021-2032) Figure 46. Asia Antibody Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Antibody Services Revenue Share by Type (2021-2032) Figure 48. Asia Antibody Services Revenue Share by Application (2021-2032) Figure 49. Asia Antibody Services Revenue Share by Region (2021-2032) Figure 50. Japan Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Antibody Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Antibody Services Revenue Share by Type (2021-2032) Figure 58. SAMEA Antibody Services Revenue Share by Application (2021-2032) Figure 59. SAMEA Antibody Services Revenue Share by Country (2021-2032) Figure 60. Brazil Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Antibody Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal
  • Polyclonal
  • Others
Applications
  • BioScience Companies
  • BioScience Research Institutions
  • Hospitals
  • Other
Companies covered
  • ThermoFisher
  • GenScript
  • Abcam
  • MBS
  • ROCKLAND
  • ProSci
  • Anaspec
  • Bio-Rad
  • Covance
  • Capra Science
  • Innovagen
  • APS
  • Randox
  • GL Biochem
  • Abgent

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antibody Services Market by Type
  3. 1.2.1 Global Antibody Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Monoclonal
  5. 1.2.3 Polyclonal
  6. 1.2.4 Others
  7. 1.3 Antibody Services Market by Application
  8. 1.3.1 Global Antibody Services Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 BioScience Companies
  10. 1.3.3 BioScience Research Institutions
  11. 1.3.4 Hospitals
  12. 1.3.5 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Antibody Services Market Dynamics
  1. 2.1 Antibody Services Industry Trends
  2. 2.2 Antibody Services Industry Drivers
  3. 2.3 Antibody Services Industry Opportunities and Challenges
  4. 2.4 Antibody Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Antibody Services Market Perspective (2021-2032)
  2. 3.2 Global Antibody Services Growth Trends by Region
  3. 3.2.1 Global Antibody Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antibody Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Antibody Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Antibody Services Revenue by Players
  2. 4.1.1 Global Antibody Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Antibody Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Antibody Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antibody Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Antibody Services Key Players Headquarters & Area Served
  7. 4.4 Global Antibody Services Players, Product Type & Application
  8. 4.5 Global Antibody Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Antibody Services Market CR5 and HHI
  11. 4.6.3 2025 Antibody Services Tier 1, Tier 2, and Tier 3
5 Antibody Services Market Size by Type
  1. 5.1 Global Antibody Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Antibody Services Revenue by Type (2021-2032)
  3. 5.3 Global Antibody Services Revenue Market Share by Type (2021-2032)
6 Antibody Services Market Size by Application
  1. 6.1 Global Antibody Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Antibody Services Revenue by Application (2021-2032)
  3. 6.3 Global Antibody Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 ThermoFisher
  2. 7.1.1 ThermoFisher Company Information
  3. 7.1.2 ThermoFisher Business Overview
  4. 7.1.3 ThermoFisher Antibody Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 ThermoFisher Antibody Services Product Portfolio
  6. 7.1.5 ThermoFisher Recent Developments
  7. 7.2 GenScript
  8. 7.2.1 GenScript Company Information
  9. 7.2.2 GenScript Business Overview
  10. 7.2.3 GenScript Antibody Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 GenScript Antibody Services Product Portfolio
  12. 7.2.5 GenScript Recent Developments
  13. 7.3 Abcam
  14. 7.3.1 Abcam Company Information
  15. 7.3.2 Abcam Business Overview
  16. 7.3.3 Abcam Antibody Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Abcam Antibody Services Product Portfolio
  18. 7.3.5 Abcam Recent Developments
  19. 7.4 MBS
  20. 7.4.1 MBS Company Information
  21. 7.4.2 MBS Business Overview
  22. 7.4.3 MBS Antibody Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 MBS Antibody Services Product Portfolio
  24. 7.4.5 MBS Recent Developments
  25. 7.5 ROCKLAND
  26. 7.5.1 ROCKLAND Company Information
  27. 7.5.2 ROCKLAND Business Overview
  28. 7.5.3 ROCKLAND Antibody Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 ROCKLAND Antibody Services Product Portfolio
  30. 7.5.5 ROCKLAND Recent Developments
  31. 7.6 ProSci
  32. 7.6.1 ProSci Company Information
  33. 7.6.2 ProSci Business Overview
  34. 7.6.3 ProSci Antibody Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 ProSci Antibody Services Product Portfolio
  36. 7.6.5 ProSci Recent Developments
  37. 7.7 Anaspec
  38. 7.7.1 Anaspec Company Information
  39. 7.7.2 Anaspec Business Overview
  40. 7.7.3 Anaspec Antibody Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Anaspec Antibody Services Product Portfolio
  42. 7.7.5 Anaspec Recent Developments
  43. 7.8 Bio-Rad
  44. 7.8.1 Bio-Rad Company Information
  45. 7.8.2 Bio-Rad Business Overview
  46. 7.8.3 Bio-Rad Antibody Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Bio-Rad Antibody Services Product Portfolio
  48. 7.8.5 Bio-Rad Recent Developments
  49. 7.9 Covance
  50. 7.9.1 Covance Company Information
  51. 7.9.2 Covance Business Overview
  52. 7.9.3 Covance Antibody Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Covance Antibody Services Product Portfolio
  54. 7.9.5 Covance Recent Developments
  55. 7.10 Capra Science
  56. 7.10.1 Capra Science Company Information
  57. 7.10.2 Capra Science Business Overview
  58. 7.10.3 Capra Science Antibody Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Capra Science Antibody Services Product Portfolio
  60. 7.10.5 Capra Science Recent Developments
  61. 7.11 Innovagen
  62. 7.11.1 Innovagen Company Information
  63. 7.11.2 Innovagen Business Overview
  64. 7.11.3 Innovagen Antibody Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Innovagen Antibody Services Product Portfolio
  66. 7.11.5 Innovagen Recent Developments
  67. 7.12 APS
  68. 7.12.1 APS Company Information
  69. 7.12.2 APS Business Overview
  70. 7.12.3 APS Antibody Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 APS Antibody Services Product Portfolio
  72. 7.12.5 APS Recent Developments
  73. 7.13 Randox
  74. 7.13.1 Randox Company Information
  75. 7.13.2 Randox Business Overview
  76. 7.13.3 Randox Antibody Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Randox Antibody Services Product Portfolio
  78. 7.13.5 Randox Recent Developments
  79. 7.14 GL Biochem
  80. 7.14.1 GL Biochem Company Information
  81. 7.14.2 GL Biochem Business Overview
  82. 7.14.3 GL Biochem Antibody Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 GL Biochem Antibody Services Product Portfolio
  84. 7.14.5 GL Biochem Recent Developments
  85. 7.15 Abgent
  86. 7.15.1 Abgent Company Information
  87. 7.15.2 Abgent Business Overview
  88. 7.15.3 Abgent Antibody Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Abgent Antibody Services Product Portfolio
  90. 7.15.5 Abgent Recent Developments
8 North America
  1. 8.1 North America Antibody Services Revenue (2021-2032)
  2. 8.2 North America Antibody Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Antibody Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Antibody Services Revenue by Type (2027-2032)
  5. 8.3 North America Antibody Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Antibody Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Antibody Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Antibody Services Revenue by Application (2027-2032)
  9. 8.5 North America Antibody Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Antibody Services Revenue by Country
  11. 8.6.1 North America Antibody Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Antibody Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Antibody Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Antibody Services Revenue (2021-2032)
  2. 9.2 Europe Antibody Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Antibody Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Antibody Services Revenue by Type (2027-2032)
  5. 9.3 Europe Antibody Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Antibody Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Antibody Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Antibody Services Revenue by Application (2027-2032)
  9. 9.5 Europe Antibody Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Antibody Services Revenue by Country
  11. 9.6.1 Europe Antibody Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Antibody Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Antibody Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Antibody Services Revenue (2021-2032)
  2. 10.2 China Antibody Services Revenue by Type (2021-2032)
  3. 10.2.1 China Antibody Services Revenue by Type (2021-2026)
  4. 10.2.2 China Antibody Services Revenue by Type (2027-2032)
  5. 10.3 China Antibody Services Revenue Share by Type (2021-2032)
  6. 10.4 China Antibody Services Revenue by Application (2021-2032)
  7. 10.4.1 China Antibody Services Revenue by Application (2021-2026)
  8. 10.4.2 China Antibody Services Revenue by Application (2027-2032)
  9. 10.5 China Antibody Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antibody Services Revenue (2021-2032)
  2. 11.2 Asia Antibody Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Antibody Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Antibody Services Revenue by Type (2027-2032)
  5. 11.3 Asia Antibody Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Antibody Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Antibody Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Antibody Services Revenue by Application (2027-2032)
  9. 11.5 Asia Antibody Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Antibody Services Revenue by Country
  11. 11.6.1 Asia Antibody Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Antibody Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Antibody Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antibody Services Revenue (2021-2032)
  2. 12.2 SAMEA Antibody Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Antibody Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Antibody Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Antibody Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Antibody Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Antibody Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Antibody Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Antibody Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Antibody Services Revenue by Country
  11. 12.6.1 SAMEA Antibody Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Antibody Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Antibody Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst